In addition, p-synephrine was predicted to exert its anti-obesity effect via calcium and cAMP signaling pathways by targeting adrenergic receptors, ADRB1, ADRB2, and ADRB3. The gene discussed is ADRB1; the disease is obesity due to melanocortin 4 receptor deficiency.